Literature DB >> 6298206

Region-specific initiation of mouse mammary tumor virus RNA synthesis by endogenous RNA polymerase II in preparations of cell nuclei.

M R Stallcup, L D Washington.   

Abstract

Adenosine 5'-O-(2-thiotriphosphate) (ATP beta S) and guanosine 5'-O-(2-thiotriphosphate) (GTP beta S) were used to demonstrate initiation of mouse mammary tumor virus (MMTV) RNA in preparations of whole nuclei from control and glucocorticoid-treated MMTV-infected rat hepatoma tissue culture cells. RNA chains initiated in the cell-free reaction retain a thiol group at the 5' end and can be separated from thiol-free RNA chains by chromatography on mercury-Sepharose. The abundance of MMTV sequences was determined by nucleic acid hybridization with filter-bound DNA representing four different regions of the MMTV genome. About six times more MMTV RNA is initiated with GTP beta S than with ATP beta S. Most of the cell-free initiation of MMTV RNA occurs within or very near a 380-nucleotide section of the proviral long terminal repeat that is the presumptive site of transcription initiation in vivo. The sensitivity of MMTV RNA initiation and synthesis to alpha-amanitin and actinomycin D are characteristic of DNA-directed transcription by RNA polymerase II. Nuclei from glucocorticoid-treated cells initiate approximately 10 times more MMTV RNA than nuclei from control cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298206

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Regulated expression of the human acetylated low density lipoprotein receptor gene and isolation of promoter sequences.

Authors:  K S Moulton; H Wu; J Barnett; S Parthasarathy; C K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  RT-PCR: 'background priming' during reverse transcription.

Authors:  B Frech; E Peterhans
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

3.  Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.

Authors:  J F Dedieu; E Vigne; C Torrent; C Jullien; I Mahfouz; J M Caillaud; N Aubailly; C Orsini; J M Guillaume; P Opolon; P Delaere; M Perricaudet; P Yeh
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Synthesis of U1 RNA in isolated nuclei from sea urchin embryos: U1 RNA is initiated at the first nucleotide of the RNA.

Authors:  G F Morris; W F Marzluff
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

5.  Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.

Authors:  S Pastore; E Fanales-Belasio; C Albanesi; L M Chinni; A Giannetti; G Girolomoni
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  Synthesis of U1 RNA in isolated mouse cell nuclei: initiation and 3'-end formation.

Authors:  S M Lobo; W F Marzluff
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

7.  Regulation of phosphoenolpyruvate carboxykinase gene transcription by insulin and cAMP: reciprocal actions on initiation and elongation.

Authors:  K Sasaki; D K Granner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Asymmetric transcription of mouse mammary tumor virus genes in vivo and in vitro.

Authors:  R S Prewitt; L D Washington; M R Stallcup
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  Mitogens and protein synthesis inhibitors induce ornithine decarboxylase gene transcription through separate mechanisms in the BC3H1 muscle cell line.

Authors:  E N Olson; G Spizz
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

10.  Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.

Authors:  P Yeh; J F Dedieu; C Orsini; E Vigne; P Denefle; M Perricaudet
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.